| For: | Ma ZG, Lv XD, Zhan LL, Chen L, Zou QY, Xiang JQ, Qin JL, Zhang WW, Zeng ZJ, Jin H, Jiang HX, Lv XP. Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway. World J Gastroenterol 2016; 22(6): 2092-2103 [PMID: 26877613 DOI: 10.3748/wjg.v22.i6.2092] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i6/2092.htm |
| Number | Citing Articles |
| 1 |
Ming-Li Zou, Ying-Ying Teng, Zhong-hua Chen, Si-Yu Liu, Yuan Jia, Kai-Wen Zhang, Jun-Jie Wu, Zheng-Dong Yuan, Xiao-Yu Tang, Shun Yu, Jun-Xing Ye, Xia Li, Xiao-Jin Zhou, Feng-Lai Yuan. The uPA System Differentially Alters Fibroblast Fate and Profibrotic Ability in Skin Fibrosis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.845956
|
| 2 |
Chong-Yang Zhang, Wei-Gang Yuan, Pei He, Jia-Hui Lei, Chun-Xu Wang. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World Journal of Gastroenterology 2016; 22(48): 10512-10522 doi: 10.3748/wjg.v22.i48.10512
|
| 3 |
Zheng Wang, Lichao Yao, Xue Hu, Mengqin Yuan, Ping Chen, Pingji Liu, Qiuling Zhang, Zhiyu Xiong, Kai Dai, Yingan Jiang. Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers. Tissue and Cell 2023; 84 doi: 10.1016/j.tice.2023.102198
|
| 4 |
Arezou Azizsoltani, Behzad Hatami, Mohammad Reza Zali, Vahideh Mahdavi, Kaveh Baghaei, Effat Alizadeh. Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling. Biomedicine & Pharmacotherapy 2023; 168 doi: 10.1016/j.biopha.2023.115777
|
| 5 |
Gan-Rong Huang, Si-Jun Wei, Yan-Qiang Huang, Wei Xing, Lu-Yao Wang, Ling-Ling Liang. Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway. World Journal of Gastroenterology 2018; 24(36): 4178-4185 doi: 10.3748/wjg.v24.i36.4178
|
| 6 |
Nanmu Yang, Jinxue Zhou, Qingjun Li, Feng Han, Zujiang Yu. miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0756-7
|
| 7 |
Min Yang, Gen Chen, Xue Zhang, Yuliang Guo, Yan Yu, Li Tian, Sheng Chang, Zhonghua Klaus Chen. Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model. Pharmacological Research 2019; 142 doi: 10.1016/j.phrs.2019.02.011
|
| 8 |
Qi Liu, Chengqian Lv, Yanan Jiang, Kunpeng Luo, Yang Gao, Jingyang Liu, Xu Zhang, Jan Mohammad Omar, Shizhu Jin. From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation. PeerJ 2022; 10 doi: 10.7717/peerj.12872
|
| 9 |
Tianpao Hao, Jingfeng Chen, Shaoce Zhi, Qiyu Zhang, Gang Chen, Fuxiang Yu. Comparison of bone marrow‑vs. adipose tissue‑derived mesenchymal stem cells for attenuating liver fibrosis. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5333
|
| 10 |
Jiwei Hou, Jingyan Shi, Ling Chen, Zhongyang Lv, Xiang Chen, Honghui Cao, Zou Xiang, Xiaodong Han. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis. Cell Communication and Signaling 2018; 16(1) doi: 10.1186/s12964-018-0300-8
|
| 11 |
He-He Hu, Gang Cao, Xia-Qing Wu, Nosratola D. Vaziri, Ying-Yong Zhao. Wnt signaling pathway in aging-related tissue fibrosis and therapies. Ageing Research Reviews 2020; 60 doi: 10.1016/j.arr.2020.101063
|
| 12 |
Patrik Mik, Katsiaryna Barannikava, Polina Surkova. Biased Quantification of Rat Liver Fibrosis—Meta-Analysis with Practical Recommendations and Clinical Implications. Journal of Clinical Medicine 2023; 12(15) doi: 10.3390/jcm12155072
|
| 13 |
Lingjia Zhao, Shasha Wu, Hua Mei, Siqi Wang, Yunduo Zhou, Chao Yang, Yizhong Yan, Guangxiu Lu, Ge Lin, Lamei Cheng. Basal Medium Affects the Biological Characteristics and Immunomodulatory Functions of MSCs. Applied Biochemistry and Biotechnology 2026; doi: 10.1007/s12010-026-05727-5
|
| 14 |
XIAO-E ZHAO, ZHENSHAN YANG, ZHEN GAO, JUNBANG GE, QIANG WEI, BAOHUA MA. 6-Bromoindirubin-3’-oxime promotes osteogenic differentiation of canine BMSCs through inhibition of GSK3β activity and activation of the Wnt/β-catenin signaling pathway. Anais da Academia Brasileira de Ciências 2019; 91(1) doi: 10.1590/0001-3765201920180459
|
| 15 |
Wei Wei, Fei Jiang, Xiao-chang Liu, Qian Su. TMEM9 mediates IL-6 and IL-1β secretion and is modulated by the Wnt pathway. International Immunopharmacology 2018; 63 doi: 10.1016/j.intimp.2018.07.036
|
| 16 |
Ji-nian Wang, Li Li, Liang-yun Li, Qi Yan, Jun Li, Tao Xu. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis. Gene 2018; 674 doi: 10.1016/j.gene.2018.06.053
|
| 17 |
Yao Wang, Lei Zhao, Fang-Zhou Jiao, Wen-Bin Zhang, Qian Chen, Zuo-Jiong Gong. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway. Hepatobiliary & Pancreatic Diseases International 2018; 17(5) doi: 10.1016/j.hbpd.2018.09.013
|
| 18 |
Xuesong Wang, Yue Wang, Wenming Lu, Jiayang Qu, Yang Zhang, Junsong Ye. Effectiveness and mechanisms of mesenchymal stem cell therapy in preclinical animal models of hepatic fibrosis: a systematic review and meta-analysis. Frontiers in Bioengineering and Biotechnology 2024; 12 doi: 10.3389/fbioe.2024.1424253
|
| 19 |
Thuong Trinh-Minh, Chih-Wei Chen, Cuong Tran Manh, Yi-Nan Li, Honglin Zhu, Xiang Zhou, Debomita Chakraborty, Yun Zhang, Simon Rauber, Clara Dees, Neng-Yu Lin, Delf Kah, Richard Gerum, Christina Bergmann, Alexander Kreuter, Christiane Reuter, Florian Groeber-Becker, Beate Eckes, Oliver Distler, Ben Fabry, Andreas Ramming, Alexandra Schambony, Georg Schett, Jörg H.W. Distler. Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis. Journal of Clinical Investigation 2024; 134(10) doi: 10.1172/JCI159884
|
| 20 |
Xiaoli Rong, Junzhi Liu, Xia Yao, Tiechao Jiang, Yimin Wang, Feng Xie. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1204-2
|
| 21 |
Jinghua Du, Weiguang Ren, Qingshan Zhang, Na Fu, Fang Han, Po Cui, Wencong Li, Lingbo Kong, Suxian Zhao, Rongqi Wang, Yuguo Zhang, Luting Yang, Li Kong, Yuemin Nan, Anelli Tiziana. Heme Oxygenase‐1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis‐Related Liver Fibrosis. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4910601
|
| 22 |
Enguo Zhang, Xiao Geng, Shan Shan, Peng Li, Shumin Li, Wentao Li, Meili Yu, Cheng Peng, Shijun Wang, Hua Shao, Zhongjun Du. Exosomes derived from bone marrow mesenchymal stem cells reverse epithelial-mesenchymal transition potentially via attenuating Wnt/β-catenin signaling to alleviate silica-induced pulmonary fibrosis. Toxicology Mechanisms and Methods 2021; 31(9) doi: 10.1080/15376516.2021.1950250
|
| 23 |
Mengmei Zhu, Tianzhen Hua, Tao Ouyang, Huofu Qian, Bing Yu, Huseyin Sumer. Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice. Stem Cells International 2021; 2021 doi: 10.1155/2021/6546780
|
| 24 |
Tao Xu, Lin-xin Pan, Yun-xuan Ge, Peng Li, Xiao-ming Meng, Cheng Huang, Jun Li. TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells. Inflammopharmacology 2018; 26(5) doi: 10.1007/s10787-017-0419-z
|
| 25 |
Chenxia Hu, Lingfei Zhao, Jinfeng Duan, Lanjuan Li. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis. Journal of Cellular and Molecular Medicine 2019; 23(3) doi: 10.1111/jcmm.14115
|
| 26 |
Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matías A. Ávila, Yulia A. Nevzorova, Francisco Javier Cubero. Fibrotic Events in the Progression of Cholestatic Liver Disease. Cells 2021; 10(5) doi: 10.3390/cells10051107
|
| 27 |
Tao Wang, Zhuo Lu, Gui-Feng Sun, Kai-Yi He, Zhi-Ping Chen, Xin-Hui Qu, Xiao-Jian Han. Natural Products in Liver Fibrosis Management: A Five-year Review. Current Medicinal Chemistry 2024; 31(31) doi: 10.2174/0109298673288458240203064112
|
| 28 |
Zaid Al-Dhamin, Ling-Di Liu, Dong-Dong Li, Si-Yu Zhang, Shi-Ming Dong, Yue-Min Nan. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of <i>in vivo</i> studies. World Journal of Gastroenterology 2020; 26(47): 7444-7469 doi: 10.3748/wjg.v26.i47.7444
|